Intestinal Perfusion After Feeding in Preterm and Term Infants
Launched by THE HOSPITAL FOR SICK CHILDREN · Mar 18, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Intestinal Perfusion After Feeding in Preterm and Term Infants," is designed to study how blood flow in the intestines changes before and after feeding in both premature and full-term infants. The goal is to understand these changes better, especially in babies who are at risk for a serious condition called necrotizing enterocolitis (NEC), which can affect their ability to digest food properly.
To participate in this study, infants must be preterm (born before 34 weeks of pregnancy) and receiving full feeding through a tube. However, infants with certain conditions, like major heart problems or infections, will not be included. The study is currently not recruiting participants, but once it starts, eligible infants will be carefully monitored before and after they eat to gather important information that could help improve care for these vulnerable babies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm infants (≤33 weeks gestational age) of any birth weight receiving full bolus enteral feeding.
- Exclusion Criteria:
- • Neonates receiving bolus enteral feeds lasting \>30 minutes or continuous enteral feeds will be excluded to avoid overlapping or close timing between pre- and post-prandial intestinal perfusion measurements.
- • Large patent ductus arteriosus (PDA)
- • Major congenital malformations
- • Suspected genetic syndrome
- • Ssuspected or confirmed infection
- • Fraction of inspired oxygen of ≥0.60 at enrollment
- • Confirmed diagnosis of necrotizing enterocolitis diagnosis. NEC will be diagnosed when at least two of the following clinical signs and one radiological sign will be present: (i) Clinical signs (1. abdominal distension; 2. abdominal tenderness; 3. abdominal discoloration; 4. blood in stool). (ii) Radiological signs (1. Pneumoperitoneum; 2. pneumatosis; 3. portal venous gas).
About The Hospital For Sick Children
The Hospital for Sick Children (SickKids) is a leading pediatric health care and research institution located in Toronto, Canada. With a commitment to advancing child health through innovative research, education, and clinical care, SickKids is recognized globally for its expertise in pediatric medicine. The hospital actively sponsors clinical trials aimed at improving treatment outcomes and enhancing the quality of life for children with various health conditions. By fostering collaboration among multidisciplinary teams and leveraging state-of-the-art facilities, SickKids strives to translate research findings into tangible advancements in pediatric care, ensuring that children receive the best possible treatments based on the latest scientific evidence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xiamen, Fujian, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported